slc25a13 Antikörper (AA 248-505)
Kurzübersicht für slc25a13 Antikörper (AA 248-505) (ABIN1886262)
Target
Alle slc25a13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 248-505
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 248 and 505 of Human SLC25A13
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.50-1.500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- slc25a13 (Solute Carrier Family 25, Member 13 (Citrin) (slc25a13))
-
Andere Bezeichnung
- SLC25A13
-
Hintergrund
-
This gene is a member of the mitochondrial carrier family.The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria.The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane.Mutations in this gene result in citrullinemia, type II.Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq]
-
Molekulargewicht
- 74 kDa
-
Gen-ID
- 10165
-
NCBI Accession
- NM_014251, NP_055066
-
Pathways
- Ribonucleoside Biosynthetic Process, Dicarboxylic Acid Transport
Target
-